Trojan horse drug could offer hope to cancer patients

A “Trojan horse” drug which attacks tumour cells from within may offer new hope to cancer patients with few options left, researchers say.

The treatment has generated promising results in people with six different cancer types, including cervical, bladder, ovarian, and lung, early trial results which were published recently in journal The Lancet Oncology show.